For the majority of these cytokines and chemokines, including those that are typically associated with MAS (IL-6, IL-18, IFN-γ, TNF-α, CXCL9) the increase was less pronounced in COVID-19 critical condition than in MAS patients (Fig. 1a). The gene discussed is IL6; the disease is COVID-19.